Cagrilintide Acetate 10 mg

What is Cagrilintide Acetate by Dragon Pharma?

Cagrilintide Acetate 10 mg is a synthetic amylin analogue designed to suppress appetite and support weight management. Manufactured by Dragon Pharma, this injectable peptide works by mimicking the hormone amylin, which regulates hunger and slows gastric emptying, helping users reduce caloric intake naturally.

Originally developed for use alongside GLP-1 agonists like Semaglutide, Cagrilintide is now used by athletes and individuals pursuing fat loss and metabolic support.

Key Benefits of Cagrilintide

• Promotes sustained appetite suppression
• Improves satiety and reduces food cravings
• Supports body recomposition during cutting cycles
• Complements peptides like Semaglutide and Tirzepatide
• May assist with long-term weight management strategies

How to Use Cagrilintide

The recommended starting dose of Cagrilintide is 0.1–0.3 mg per injection, administered subcutaneously once daily. It is typically used in cycles lasting 4–12 weeks and may be increased gradually based on user tolerance and physician guidance. Always consult a healthcare provider before starting a peptide protocol.

Shipping and Lab Testing

Cagrilintide Acetate is shipped securely from both domestic US and international depots. Every vial undergoes professional lab testing to ensure purity, sterility, and potency. Below is the latest lab verification image for this product:

Explore More Peptides from Dragon Pharma

• Semaglutide 5 mg – GLP-1 receptor agonist for weight loss
• Survodutide 10 mg – Dual agonist for weight management
• AOD 9604 – Fat-burning peptide

Visit our full peptides shop or check the complete Dragon Pharma lineup at our trusted steroids shop.

Learn more about the science behind Cagrilintide on PubChem.

Frequently Asked Questions